Author:
Matsukura Suchitra,Nakamura Yuji,Cao Xin,Wada Takeshi,Izumi-Nakaseko Hiroko,Ando Kentaro,Sugiyama Atsushi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference19 articles.
1. Kaufman, E. S., Zimmermann, P. A., Wang, T., Dennish, G. W. I. I. I., Barrell, P. D., Chandler, M. L., & Greene, H. L. (2004). Risk of proarrhythmic events in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study: A multivariate analysis. Journal of the American College of Cardiology, 44, 1276–1282.
2. Zimetbaum, P. (2012). Antiarrhythmic drug therapy for atrial fibrillation. Circulation, 125, 381–389.
3. Sugiyama, A., Satoh, Y., & Hashimoto, K. (2001). Acute electropharmacological effects of intravenously administered amiodarone assessed in the in vivo canine model. Japanese Journal of Pharmacology, 87, 74–82.
4. Takahara, A., Nakamura, Y., & Sugiyama, A. (2008). Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion-channel blockers bepridil and amiodarone. European Journal of Pharmacology, 596, 127–131.
5. Yoshida, H., Sugiyama, A., Satoh, Y., Ishida, Y., Yoneyama, M., Kugiyama, K., & Hashimoto, K. (2002). Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model. Circulation Journal, 66, 758–762.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献